VIA
WVE icon

Vident Investment Advisory’s Wave Life Sciences WVE Stock Holding History

Vident Investment Advisory’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-12,914
Closed -$494K – 1012
2018
Q2 		$494K Buy
12,914
+2,744
+27% +$118K 0.02% 665
2018
Q1 		$418K Buy
+10,170
New +$428K 0.02% 688
2017
Q3 		– Sell
-14,057
Closed -$261K – 780
2017
Q2 		$261K Buy
14,057
+3,407
+32% +$73.4K 0.02% 414
2017
Q1 		$293K Buy
+10,650
New +$297K 0.03% 392
2016
Q4 		– Sell
-19,342
Closed -$628K – 398
2016
Q3 		$628K Sell
19,342
-12,990
-40% -$307K 0.08% 320
2016
Q2 		$669K Buy
+32,332
New +$504K 0.09% 334

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Vident Investment Advisory's WVE Position: Q3 2018 in Review

Vident Investment Advisory sold out of Wave Life Sciences (WVE) in Q3 2018, closing a stake of 12,914 shares — an estimated $494K sold.

Vident Investment Advisory first reported a position in WVE in Q2 2016 and held it in 6 quarters. The position peaked at $669K in Q2 2016. 92 funds tracked by Wall St. Rank hold WVE as of Q3 2018.

  • Vident Investment Advisory reported no remaining Wave Life Sciences position as of Q3 2018 after selling out during the quarter.
  • Vident Investment Advisory sold 12,914 Wave Life Sciences shares in Q3 2018, an estimated $494K.
  • Vident Investment Advisory first reported a position in Wave Life Sciences in Q2 2016 and held it in 6 quarters.
  • Vident Investment Advisory's Wave Life Sciences position peaked at $669K in Q2 2016.
  • 92 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2018.

Based on Vident Investment Advisory's 13F filing for Q3 2018, filed 14 Nov 2018.